Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Learn effective ways to make quick cash for emergency expenses. Be ready for financial surprises with these practical tips.
22,319 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Nebius inked a $27 billion AI infrastructure deal with Meta, locking in vast capacity and signaling its edge in the n...
Tech ETFs split into three paths in 2026: broad mega-cap funds stumble, cybersecurity themes gain ground, and AI infr...
Circle Internet Group stock has tumbled amid regulatory whispers around stablecoins. This guide breaks down what the ...
IonQ is leading the field among pure-play quantum stocks in 2026, delivering a positive year-to-date return while its...
Roadrunner, the AI-powered CPQ startup, today disclosed a $27 million funding round led by Kleiner Perkins and FOUNDE...
AI-driven threats are accelerating demand for security software, and a trio of under-$30 cyber names could offer mean...
A major fund is doubling down on Lionsgate Studios as shares skyrocket. Learn what know about this bet, the strategy ...
A long-running trend shows the sector wall street calls defensive, led by utilities, delivering returns that outpace ...
Berkshire Hathaway sold stocks in Q1, exiting 16 positions as the conglomerate maintains a heavy concentration in sev...
Stocks hover near record levels while consumer sentiment sinks to multi-decade lows. This piece examines trump’s bull...
US stocks closed higher on Friday as a wave of fresh analyst calls lifted growth names such as Best Buy, Dell Technol...